Cargando…

Antifungal De-Escalation Is Safe in Critically Ill Patients Treated For Suspected Or Documented Invasive Candidiasis. Data From The Amarcand2 Study

Detalles Bibliográficos
Autores principales:	Bailly, S, Leroy, O, Montravers, P, Constantin, JM, Dupont, H, Guillemot, D, Lortholary, O, Mira, JP, Perrigault, PF, Gangneux, JP, Azoulay, E, Timsit, JF
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2015
Materias:	Oral Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4797565/ http://dx.doi.org/10.1186/2197-425X-3-S1-A5

Ejemplares similares

Epidemiological cohort study of systemic antifungal therapy for suspected or confirmed invasive candidiasis in the ICU: the Amarcand2 study
por: Constantin, J, et al.
Publicado: (2015)

Systemic antifungal therapy for proven or suspected invasive candidiasis: the AmarCAND 2 study
por: Leroy, Olivier, et al.
Publicado: (2016)

Clinical Impact of Antifungal Susceptibility, Biofilm Formation and Mannoside Expression of Candida Yeasts on the Outcome of Invasive Candidiasis in ICU: An Ancillary Study on the Prospective AmarCAND2 Cohort
por: Gangneux, Jean-Pierre, et al.
Publicado: (2018)

Comparison of albicans vs. non-albicans candidemia in French intensive care units
por: Leroy, Olivier, et al.
Publicado: (2010)

Candidiasis and Mechanisms of Antifungal Resistance
por: Bhattacharya, Somanon, et al.
Publicado: (2020)

Epidemiology and antifungal resistance in invasive candidiasis
por: Rodloff, AC, et al.
Publicado: (2011)

Conventional and alternative antifungal therapies to oral candidiasis
por: Anibal, Paula Cristina, et al.
Publicado: (2010)

Impact of early catheter removal during treatment of invasive candidiasis: analysis from two phase 3 micafungin trials
por: Nucci, M, et al.
Publicado: (2009)

Propranolol Ameliorates the Antifungal Activity of Azoles in Invasive Candidiasis
por: Mayandi, Venkatesh, et al.
Publicado: (2023)

808. Outcomes of Invasive Candidiasis Stratified by Antifungal Therapy
por: Box, Maggie, et al.
Publicado: (2023)

Hepatosplenic Candidiasis Without Prior Documented Candidemia: An Underrecognized Diagnosis?
por: van Prehn, Joffrey, et al.
Publicado: (2017)

Improving documentation of treatment escalation decisions in acute care
por: Dahill, Mark, et al.
Publicado: (2013)

Outcomes of Neonatal Candidiasis: The Impact of Delayed Initiation of Antifungal Therapy
por: Cahan, Heather, et al.
Publicado: (2011)

Antifungal activity of the piroctone olamine in experimental intra-abdominal candidiasis
por: do Couto, Fabíola Maria Marques, et al.
Publicado: (2016)

Candidiasis in Pediatrics; Identification and In vitro Antifungal Susceptibility of the Clinical Isolates
por: Mohammadi, R, et al.
Publicado: (2016)

Vulvovaginal candidiasis: species distribution of Candida and their antifungal susceptibility pattern
por: Bitew, Adane, et al.
Publicado: (2018)

Biomarker-guided antifungal stewardship policies for patients with invasive candidiasis
por: Honarvar, Behnam, et al.
Publicado: (2018)

Antifungal Treatment is Not Required for Immunocompetent Individuals With Asymptomatic Esophageal Candidiasis
por: Min, Yang Won, et al.
Publicado: (2015)

Therapeutic tools for oral candidiasis: Current and new antifungal drugs
por: Quindós, Guillermo, et al.
Publicado: (2019)

The Role of Novel Antifungals in the Management of Candidiasis: A Clinical Perspective
por: Ordaya, Eloy E., et al.
Publicado: (2023)

Does (18)F-FDG PET/CT add value to conventional imaging in clinical assessment of chronic disseminated candidiasis?
por: Rammaert, Blandine, et al.
Publicado: (2022)

A Randomized, Placebo-controlled Trial of Preemptive Antifungal Therapy for the Prevention of Invasive Candidiasis Following Gastrointestinal Surgery for Intra-abdominal Infections
por: Knitsch, Wolfgang, et al.
Publicado: (2015)

Intra-Abdominal Candidiasis: The Importance of Early Source Control and Antifungal Treatment
por: Vergidis, Pascalis, et al.
Publicado: (2016)

Surgical management of chronic hyperplastic candidiasis refractory to systemic antifungal treatment
por: Shah, Neha, et al.
Publicado: (2017)

Quinolines derivatives as promising new antifungal candidates for the treatment of candidiasis and dermatophytosis
por: da Rosa Monte Machado, Gabriella, et al.
Publicado: (2020)

Molecular identification and antifungal susceptibility profile of yeast from vulvovaginal candidiasis
por: Shi, Yu, et al.
Publicado: (2020)

Treatment of candidemia and invasive candidiasis in the intensive care unit: post hoc analysis of a randomized, controlled trial comparing micafungin and liposomal amphotericin B
por: Dupont, Bertrand F, et al.
Publicado: (2009)

Highly-cited estimates of the cumulative incidence and recurrence of vulvovaginal candidiasis are inadequately documented
por: Rathod, Sujit D, et al.
Publicado: (2014)

Caspase-1 and ASC but not NLRP3 mediate antifungal defense in candidiasis sepsis
por: Veerdonk, F van de, et al.
Publicado: (2009)

Correction to: Molecular identification and antifungal susceptibility profile of yeast from vulvovaginal candidiasis
por: Shi, Yu, et al.
Publicado: (2022)

In vitro antifungal susceptibility pattern of Candida species isolated from gastroesophageal candidiasis
por: Mirshekar, Mohsen, et al.
Publicado: (2021)

Comparison of the antifungal effect of voriconazole and fluconazole on oral candidiasis before and during radiotherapy
por: Golestannejad, Zahra, et al.
Publicado: (2022)

Prophylaxis of Antifungal Drugs against Systemic Fungemia induced by Oral Candidiasis in Mice
por: Ninomiya, Kazunori, et al.
Publicado: (2023)

Pharmacokinetic and pharmacodynamic considerations for antifungal therapy optimisation in the treatment of intra-abdominal candidiasis
por: Novy, Emmanuel, et al.
Publicado: (2023)

Antifungal stewardship in critical care: Implementing a diagnostics-driven care pathway in the management of invasive candidiasis
por: Hare, D., et al.
Publicado: (2020)

Antifungal management in ICU: careful follow-up of voriconazole prescription needed!
por: Reizine, Florian, et al.
Publicado: (2023)

Demographic and outcome differences in ICU patients with proven invasive candidiasis, possible invasive candidiasis and probable candida colonization: analysis of the EPIC II study population
por: Kett, D, et al.
Publicado: (2011)

Antifungal Activity of Brazilian Propolis Microparticles against Yeasts Isolated from Vulvovaginal Candidiasis
por: Dota, Kelen Fátima Dalben, et al.
Publicado: (2011)

Antifungal Susceptibility Testing with Etest for Candida Species Isolated from Patients with Oral Candidiasis
por: Song, You Bum, et al.
Publicado: (2015)

Antifungal Potential of Host Defense Peptide Mimetics in a Mouse Model of Disseminated Candidiasis
por: Chowdhury, Mobaswar Hossain, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_vbujjfsbof6cfq6uld41um3g2a